Please wait while the formulary information is being retrieved.
DAXXIFY (daxibotulinumtoxinA-lanm)
- deep lines between eyebrows
100 unit intramuscular solution
- Dosage information is not available
- None
Contraindicated
- Adoxa
- amikacin
- Avidoxy
- Compound 347
- demeclocycline
- dextromethorphan-quinidine
- Doryx
- Doxy-100
- doxycycline calcium
- doxycycline hyclate
- doxycycline monohydrate
- enflurane
- Forane
- gentamicin
- gentamicin in NaCl (iso-osm)
- gentamicin sulfate (ped) (PF)
- gentamicin sulfate (PF)
- isoflurane
- Minocin
- minocycline
- Monodox
- Morgidox
- neomycin
- Nuedexta
- Oracea
- paromomycin
- Qualaquin
- quinidine gluconate
- quinidine sulfate
- quinine sulfate
- sevoflurane
- Sojourn
- Solodyn
- streptomycin
- Terrell
- tetracycline
- tigecycline
- tobramycin in 0.9 % NaCl
- tobramycin sulfate
- Tygacil
- Ultane
- Vibramycin
Severe
Moderate
- Acanya
- Baciim
- bacitracin
- Benzaclin
- Benzaclin Pump
- Capastat
- capreomycin
- Cerebyx
- Cleocin
- Cleocin In 5 % Dextrose
- Cleocin T
- Clindacin Etz
- Clindacin P
- Clindacin Pac
- Clindagel
- clindamycin HCl
- clindamycin in dextrose 5%
- clindamycin palmitate HCl
- Clindamycin Pediatric
- clindamycin phos-skin clnsr 19
- clindamycin phosphate
- clindamycin-benzoyl peroxide
- clindamycin-tretinoin
- Clindesse
- colistin (colistimethate Na)
- Coly-mycin M Parenteral
- Dilantin
- Dilantin Extended
- Dilantin Infatabs
- Dilantin Kapseal
- Dilantin-125
- Duac
- ethotoin
- Evoclin
- fosphenytoin
- Lincocin
- lincomycin
- Peganone
- Phenytek
- phenytoin
- phenytoin sodium
- phenytoin sodium extended
- polymyxin B sulfate
- vancomycin
- vancomycin in D5W
- vancomycin in dextrose iso-osm
- Veltin
- Ziana
- None
Contraindicated
- Amyotrophic lateral sclerosis
- Atherosclerotic cardiovascular disease
- Dysphagia
- Eaton-lambert syndrome
- Myasthenia gravis
- Neuromuscular disease
- Peripheral motor neuropathy
- Respiratory depression
Severe
Moderate
- None
DAXXIFY (daxibotulinumtoxinA-lanm)
- deep lines between eyebrows
- Dysphagia
- Lagophthalmos
- Muscle weakness
- Voice change
- Back pain
- Blepharoptosis
- Bronchitis
- Cough
- Dysuria
- Ecchymosis
- Eyelid edema
- Fatigue
- Headache disorder
- Influenza
- Injection site sequelae
- Nausea
- Neck pain
- Ocular irritation
- Pharyngitis
- Rhinitis
- Upper respiratory infection
- Urinary retention
- Urinary tract infection
- Xerostomia
More Frequent
Severe
Less Severe
- Diplopia
- Fever
- Infection
- Pruritus of skin
- Skin rash
- Visual changes
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Acute myocardial infarction
- Acute respiratory distress syndrome
- Anaphylaxis
- Aspiration pneumonia
- Botulism
- Brachial plexus disorder
- Cardiac arrhythmia
- Corneal ulcer
- Dysarthria
- Dyspnea
- Entropion
- Erythema
- Erythema multiforme
- Hearing loss
- Hematoma
- Hypersensitivity drug reaction
- Keratitis
- Muscle atrophy
- Pneumonia
- Respiratory depression
- Seizure disorder
- Serum sickness
- Urinary incontinence
Less Severe
- Acute abdominal pain
- Alopecia
- Anorexia
- Arthralgia
- Blurred vision
- Chest pain
- Diarrhea
- Dry eye
- Edema
- Excessive granulation tissue
- Eyes vertical deviation
- Facial palsy
- Flu-like symptoms
- Gait abnormality
- General weakness
- Heavy feeling
- Hematuria
- Hyperhidrosis
- Hypertonia
- Hypoesthesia
- Madarosis of eyelid
- Malaise
- Muscle fasciculation
- Musculoskeletal pain
- Myalgia
- Paresthesia
- Peripheral neuropathy
- Photophobia
- Psoriasiform eruption
- Retrobulbar hemorrhage
- Sinusitis
- Stinging of skin
- Strabismus
- Symptoms of anxiety
- Syncope
- Tinnitus
- Urticaria
- Vertigo
- Vomiting
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
(daxi) (pra) botulinumtoxin A
Safety and efficacy not established in pediatrics.
- 1 Day – 18 Years
- Safety and efficacy not established in pediatrics.
Daxibotulinumtoxina-lanm
- Severity Level:
2
- Additional Notes: Insufficient human data available
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Daxibotulinumtoxina-lanm
Insufficient human data available
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient human data available |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- See also Uses section. This medication can spread to other parts of the body after your injection, causing serious (possibly fatal) side effects. These can occur hours or even weeks after the injection.<br /><br />However, the chances of such serious side effects occurring when this medication is used for migraines or skin conditions such as wrinkles, eye spasm, or excessive sweating are extremely unlikely. Children being treated for muscle stiffness/spasms have the greatest risk of these effects, as well as anyone that has certain medical conditions (see Precautions section). Discuss the risks and benefits of this medication with your doctor. Get medical help right away if any of these very serious side effects occur: chest pain, difficulty breathing, excessive muscle weakness, irregular heartbeat, severe difficulty swallowing or speaking, loss of bladder control.
| Glabellar lines | |
| L98.8 | Other specified disorders of the skin and subcutaneous tissue |
| Spasmodic torticollis | |
| G24.3 | Spasmodic torticollis |
| 0-9 | A-Z |
|---|---|
| G24.3 | Spasmodic torticollis |
| L98.8 | Other specified disorders of the skin and subcutaneous tissue |
Formulary Reference Tool